Brainstorm Cell Therapeutics reported $-3.04M in EBITDA for its fiscal quarter ending in March of 2025.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Biogen USD 450.8M 198.9M Jun/2026
Brainstorm Cell Therapeutics USD -3.04M 99K Mar/2025
Cipla INR 13.88B 154.2M Sep/2026
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -8.84M 180K Jun/2026
CSL USD 3.13B 1.17B Dec/2025
Cytokinetics USD -160.3M 9.02M Jun/2026
Gilead Sciences USD -9.31B 12.82B Jun/2026
Grifols EUR 482.04M 7.04M Sep/2025
Halozyme Therapeutics USD 336.16M 7.34M Sep/2026
Mesoblast USD -17.08M 3.21M Jun/2026